CA2728063A1 - Pyrazole compounds 436 - Google Patents
Pyrazole compounds 436 Download PDFInfo
- Publication number
- CA2728063A1 CA2728063A1 CA2728063A CA2728063A CA2728063A1 CA 2728063 A1 CA2728063 A1 CA 2728063A1 CA 2728063 A CA2728063 A CA 2728063A CA 2728063 A CA2728063 A CA 2728063A CA 2728063 A1 CA2728063 A1 CA 2728063A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7388308P | 2008-06-19 | 2008-06-19 | |
US61/073,883 | 2008-06-19 | ||
PCT/GB2009/050684 WO2009153592A1 (en) | 2008-06-19 | 2009-06-17 | Pyrazole compounds 436 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2728063A1 true CA2728063A1 (en) | 2009-12-23 |
Family
ID=40935715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2728063A Abandoned CA2728063A1 (en) | 2008-06-19 | 2009-06-17 | Pyrazole compounds 436 |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090318468A1 (es) |
EP (1) | EP2328872A1 (es) |
JP (1) | JP2011524888A (es) |
KR (1) | KR20110020904A (es) |
CN (1) | CN102123989A (es) |
AR (1) | AR072261A1 (es) |
AU (1) | AU2009261683A1 (es) |
BR (1) | BRPI0914233A2 (es) |
CA (1) | CA2728063A1 (es) |
CL (1) | CL2010001470A1 (es) |
CO (1) | CO6351726A2 (es) |
CR (1) | CR11857A (es) |
DO (1) | DOP2010000387A (es) |
EA (1) | EA201100030A1 (es) |
EC (1) | ECSP10010693A (es) |
IL (1) | IL210082A0 (es) |
MX (1) | MX2010014234A (es) |
PE (1) | PE20110062A1 (es) |
SV (1) | SV2010003767A (es) |
TW (1) | TW201002693A (es) |
UY (1) | UY31918A (es) |
WO (1) | WO2009153592A1 (es) |
ZA (1) | ZA201100471B (es) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
EP2512476A1 (en) * | 2009-12-18 | 2012-10-24 | Novartis AG | Method for treating haematological cancers |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
ES2746288T3 (es) | 2012-02-28 | 2020-03-05 | Astellas Pharma Inc | Compuesto heterocíclico aromático que contiene nitrógeno |
LT3176170T (lt) | 2012-06-13 | 2019-04-25 | Incyte Holdings Corporation | Pakeisti tricikliniai junginiai, kaip fgfr inhibitoriai |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
PL403149A1 (pl) * | 2013-03-14 | 2014-09-15 | Celon Pharma Spółka Akcyjna | Nowe związki pochodne pirazolilobenzo[d]imidazolu |
WO2014139145A1 (en) * | 2013-03-15 | 2014-09-18 | Hutchison Medipharma Limited | Novel pyrimidine and pyridine compounds and usage thereof |
DK2986610T5 (en) | 2013-04-19 | 2018-12-10 | Incyte Holdings Corp | BICYCLIC HETEROCYCLES AS FGFR INHIBITORS |
JP6084291B2 (ja) | 2013-07-18 | 2017-02-22 | 大鵬薬品工業株式会社 | Fgfr阻害剤の間歇投与用抗腫瘍剤 |
JP6084292B2 (ja) | 2013-07-18 | 2017-02-22 | 大鵬薬品工業株式会社 | Fgfr阻害剤耐性癌の治療薬 |
RU2658821C1 (ru) | 2014-08-18 | 2018-06-25 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Соль моноциклического производного пиридина и ее кристалл |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
CN107438607B (zh) | 2015-02-20 | 2021-02-05 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
CA2980888C (en) | 2015-03-31 | 2018-03-06 | Taiho Pharmaceutical Co., Ltd. | Crystal of 3,5-disubstituted benzene alkynyl compound |
WO2017150725A1 (ja) * | 2016-03-04 | 2017-09-08 | 大鵬薬品工業株式会社 | 悪性腫瘍治療用製剤及び組成物 |
US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
KR20200041361A (ko) | 2017-08-15 | 2020-04-21 | 씨에스피씨 종콰이 팔마씨우티컬 테크놀로지 (스자좡) 컴퍼니 리미티드 | Fgfr 억제제 및 그의 의학적 용도 |
EP4353222A1 (en) | 2018-03-19 | 2024-04-17 | Taiho Pharmaceutical Co., Ltd. | Use of sodium alkyl sulfate |
MX2020008610A (es) | 2018-03-28 | 2020-09-21 | Eisai R&D Man Co Ltd | Agente terapeutico para carcinoma hepatocelular. |
CN110317173B (zh) * | 2018-03-30 | 2022-10-11 | 上海奕拓医药科技有限责任公司 | 用作fgfr不可逆抑制剂的酰胺基吡唑类化合物 |
WO2019213506A1 (en) | 2018-05-04 | 2019-11-07 | Incyte Corporation | Salts of an fgfr inhibitor |
PE20210920A1 (es) | 2018-05-04 | 2021-05-19 | Incyte Corp | Formas solidas de un inhibidor de fgfr y procesos para prepararlas |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
KR20210142154A (ko) | 2019-03-21 | 2021-11-24 | 옹쎄오 | 암 치료를 위한 키나제 억제제와 조합된 dbait 분자 |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
KR20220100879A (ko) | 2019-10-14 | 2022-07-18 | 인사이트 코포레이션 | Fgfr 저해제로서의 이환식 헤테로사이클 |
WO2021076728A1 (en) | 2019-10-16 | 2021-04-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
CA3159348A1 (en) | 2019-11-08 | 2021-05-14 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
JP2023505258A (ja) | 2019-12-04 | 2023-02-08 | インサイト・コーポレイション | Fgfr阻害剤としての三環式複素環 |
PE20221504A1 (es) | 2019-12-04 | 2022-09-30 | Incyte Corp | Derivados de un inhibidor de fgfr |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57150846A (en) * | 1981-03-13 | 1982-09-17 | Konishiroku Photo Ind Co Ltd | Photographic element |
JPH0511414A (ja) * | 1991-07-02 | 1993-01-22 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
CA2119155C (en) * | 1991-10-18 | 1999-06-15 | Dennis Paul Phillion | Fungicides for the control of take-all disease of plants |
HRP921338B1 (en) * | 1992-10-02 | 2002-04-30 | Monsanto Co | Fungicides for the control of take-all disease of plants |
US6271237B1 (en) * | 1997-12-22 | 2001-08-07 | Dupont Pharmaceuticals Company | Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
GB9823103D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
ATE286026T1 (de) * | 1999-02-10 | 2005-01-15 | Mitsubishi Pharma Corp | Amid-derivate und deren medizinische verwendung |
EA005373B1 (ru) * | 1999-08-12 | 2005-02-24 | Фармация Италия С.П.А. | Производные 3(5)-аминопиразола, способ их получения и их применение в качестве противоопухолевых средств |
EP1223944B1 (en) * | 1999-09-24 | 2007-01-03 | SmithKline Beecham Corporation | Thrombopoietin mimetics |
HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
AU2001290258A1 (en) * | 2000-09-22 | 2002-04-02 | Nihon Nohyaku Co. Ltd. | N-(4-pyrazolyl)amide derivatives, chemicals for agricultural and horticultural use, and usage of the same |
ATE548031T1 (de) * | 2000-12-18 | 2012-03-15 | Inst Med Molecular Design Inc | Inhibitoren gegen die produktion und freisetzung entzündungfördernder zytokine |
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
JPWO2003103648A1 (ja) * | 2002-06-05 | 2005-10-06 | 株式会社医薬分子設計研究所 | 糖尿病治療薬 |
EA008622B1 (ru) * | 2002-06-05 | 2007-06-29 | Инститьют Оф Медисинал Молекьюлар Дизайн. Инк. | Ингибиторы ассоциированной с иммунитетом протеинкиназы |
AU2003242103A1 (en) * | 2002-06-06 | 2003-12-22 | Institute Of Medicinal Molecular Design, Inc | Antiallergic agents |
US20060004010A1 (en) * | 2002-07-10 | 2006-01-05 | Hiromu Habashita | Ccr4 antagonist and medical use thereof |
AU2003253686A1 (en) * | 2002-08-01 | 2004-02-23 | Pharmacia & Upjohn Company Llc | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
US20040220170A1 (en) * | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
US7115359B2 (en) * | 2003-07-25 | 2006-10-03 | Konica Minolta Medical & Graphic, Inc. | Photothermographic material |
US7432271B2 (en) * | 2003-09-02 | 2008-10-07 | Bristol-Myers Squibb Company | Pyrazolyl inhibitors of 15-lipoxygenase |
US20050171172A1 (en) * | 2003-11-13 | 2005-08-04 | Ambit Biosciences Corporation | Amide derivatives as PDGFR modulators |
US7652146B2 (en) * | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
US7253204B2 (en) * | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
ATE464303T1 (de) * | 2004-04-28 | 2010-04-15 | Vertex Pharma | Als inhibitoren von rock und anderen proteinkinasen geeignete zusammensetzungen |
US7737149B2 (en) * | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
-
2009
- 2009-06-17 JP JP2011514127A patent/JP2011524888A/ja active Pending
- 2009-06-17 EP EP09766153A patent/EP2328872A1/en not_active Withdrawn
- 2009-06-17 AU AU2009261683A patent/AU2009261683A1/en not_active Abandoned
- 2009-06-17 CN CN2009801328063A patent/CN102123989A/zh active Pending
- 2009-06-17 KR KR1020117000437A patent/KR20110020904A/ko not_active Application Discontinuation
- 2009-06-17 EA EA201100030A patent/EA201100030A1/ru unknown
- 2009-06-17 BR BRPI0914233A patent/BRPI0914233A2/pt not_active Application Discontinuation
- 2009-06-17 WO PCT/GB2009/050684 patent/WO2009153592A1/en active Application Filing
- 2009-06-17 CA CA2728063A patent/CA2728063A1/en not_active Abandoned
- 2009-06-17 MX MX2010014234A patent/MX2010014234A/es not_active Application Discontinuation
- 2009-06-17 PE PE2010001161A patent/PE20110062A1/es not_active Application Discontinuation
- 2009-06-18 TW TW098120493A patent/TW201002693A/zh unknown
- 2009-06-18 UY UY0001031918A patent/UY31918A/es not_active Application Discontinuation
- 2009-06-19 US US12/487,838 patent/US20090318468A1/en not_active Abandoned
- 2009-06-19 AR ARP090102262A patent/AR072261A1/es unknown
-
2010
- 2010-12-16 IL IL210082A patent/IL210082A0/en unknown
- 2010-12-17 DO DO2010000387A patent/DOP2010000387A/es unknown
- 2010-12-17 CL CL2010001470A patent/CL2010001470A1/es unknown
- 2010-12-17 CR CR11857A patent/CR11857A/es not_active Application Discontinuation
- 2010-12-17 EC EC2010010693A patent/ECSP10010693A/es unknown
- 2010-12-17 SV SV2010003767A patent/SV2010003767A/es not_active Application Discontinuation
-
2011
- 2011-01-18 ZA ZA2011/00471A patent/ZA201100471B/en unknown
- 2011-01-19 CO CO11005446A patent/CO6351726A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0914233A2 (pt) | 2015-11-03 |
IL210082A0 (en) | 2011-02-28 |
EP2328872A1 (en) | 2011-06-08 |
CO6351726A2 (es) | 2011-12-20 |
SV2010003767A (es) | 2011-05-20 |
CN102123989A (zh) | 2011-07-13 |
KR20110020904A (ko) | 2011-03-03 |
ECSP10010693A (es) | 2011-01-31 |
TW201002693A (en) | 2010-01-16 |
ZA201100471B (en) | 2012-06-27 |
JP2011524888A (ja) | 2011-09-08 |
CL2010001470A1 (es) | 2011-05-06 |
AU2009261683A1 (en) | 2009-12-23 |
EA201100030A1 (ru) | 2011-08-30 |
MX2010014234A (es) | 2011-03-25 |
AR072261A1 (es) | 2010-08-18 |
US20090318468A1 (en) | 2009-12-24 |
DOP2010000387A (es) | 2012-09-30 |
PE20110062A1 (es) | 2011-03-09 |
WO2009153592A1 (en) | 2009-12-23 |
CR11857A (es) | 2011-02-25 |
UY31918A (es) | 2010-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2728063A1 (en) | Pyrazole compounds 436 | |
US10301267B2 (en) | Compounds | |
WO2009019518A1 (en) | Pyrimidine compounds having a fgfr inhibitory effect | |
KR101464384B1 (ko) | mTOR 억제제로서 피리도피리미딘, 피라조피리미딘 및피리미도피리미딘 유도체 | |
WO2009056886A1 (en) | Pyrimidine derivatives and their use as modulators of fgfr activity | |
WO2009007390A2 (en) | 2-pyraz inylbenz imidazole derivatives as receptor tyrosine kinase inhibitors | |
KR20090024270A (ko) | 암 치료에 유용한 피리미딘 유도체 | |
JP2010536841A (ja) | 増殖性疾患治療のためのttk/mps1阻害剤としての2−アニリノプリン−8−オン類 | |
KR20090042855A (ko) | Mtor 억제제로서의 2-메틸모르폴린 피리도-, 피라조- 및 피리미도-피리미딘 유도체 | |
JP2011524411A (ja) | ピリジン化合物 | |
CN101010317A (zh) | 作为磷脂酰肌醇(pi)3-激酶抑制剂的2,4,6-三取代的嘧啶及其在癌症治疗中的用途 | |
WO2008009909A1 (en) | Pteridimones as modulators of polo-like kinase | |
US20090312336A1 (en) | Dihydropteridine compounds as anti proliferative agents | |
WO2008040951A1 (en) | Compounds | |
CN109369656B (zh) | 喹啉类化合物硫酸盐的晶型、制备方法、组合物与应用 | |
WO2017177958A1 (zh) | 一种稠环化合物、其制备方法和应用及其中间体化合物 | |
Ren et al. | EGFR/HER-2 inhibitors: synthesis, biological evaluation and 3D-QSAR analysis of dihydropyridine-containing thiazolinone derivatives | |
US20230303544A1 (en) | Lmo2 protein inhibitors | |
US20080269266A1 (en) | Novel compounds 747 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |
Effective date: 20130618 |